Laurence Levine, MD
Urology · Chicago, ILNPI 1922072131
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (48.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Coloplast at 56.0% of the total. Reporting peaked in 2019 at $41,728 and has fallen 95.0% since, to $2,077 in 2025. Among urology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 324 payments — averaging $389.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$71K
- Boston Scientific$33K
- Innovation Technologies Inc$17K
- Clarus Therapeutics Inc.$2K
- Endo Pharmaceuticals Inc.$646
- Metuchen Pharmaceuticals$500
- plus $2K from 12 others
Across 10 payments — averaging $7949.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Innovation Technologies Inc$79K
- Coloplast$658
What the payments were for
- Consulting fees$20,20316%
- Speaking & faculty fees$27,66722%
- Travel & lodging$4,9804%
- Food & beverage$11,7239%
- Education$61,64649%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 134 | $70,708 |
| Boston Scientific | 138 | $33,490 |
| Innovation Technologies Inc | 21 | $16,530 |
| Clarus Therapeutics Inc. | 2 | $2,150 |
| Endo Pharmaceuticals Inc. | 3 | $646 |
| Metuchen Pharmaceuticals | 1 | $500 |
| Procept Biorobotics Corporation | 5 | $452 |
| Healthtronics Stone Solutions, LLC | 1 | $447 |
| Palette Life Sciences, Inc. | 2 | $330 |
| Olympus America Inc. | 8 | $256 |
| Rigicon,inc. | 1 | $217 |
| Laborie Medical Technologies Corp. | 1 | $176 |
| Stryker | 1 | $149 |
| 180 Medical, Inc. | 2 | $55 |
| Antares Pharma, Inc. | 1 | $50 |
| Calyxo, Inc. | 1 | $28 |
| SRS Medical Systems, Inc. | 1 | $20 |
| Kerecis Limited | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$69,627
- Irrisept$16,318
- AMS 700 CXR RTE KIT$6,602
- TACTRA$6,480
- JATENZO$6,450
- AMS$4,825
- AdVance XP$4,750
- AMS 700$3,293
- GENERAL - THERAPIES$704
- GENERAL ERECTILE DYSFUNCTION$665
- XIAFLEX$617
- Stendra$500
- Mobile Cryoblation Services$447
- AquaBeam Robotic System$286
- RIGI10 MALLEABLE PENILE PROSTHESIS$217
- Optilume BPH Drug Coated Balloon Catheter$176
- NEW PRODUCT DEVELOPMENT$149
- AQUABEAM SYSTEM$123
- GENERAL MALE SUI$108
- iTIND System$105
How this compares
$126,218 in reported general payments places this provider in the 95th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 25 | $17,464 |
| Solifenacin Succinate | 44 | $4,269 |
| Testosterone | 20 | $3,300 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 128 | $2,395 |
| Testosterone Cypionate | 36 | $2,229 |
| Finasteride | 123 | $1,755 |
| Tamsulosin Hcl | 59 | $991 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $653 |
| Cephalexin | 138 | $619 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $336 |
| Oxybutynin Chloride | 12 | $139 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $70 |
| Ciprofloxacin Hcl | 16 | $47 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $31 |
Paid to pharmacies, not to this prescriber.
Other urology in Chicago
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Amy KrambeckChicago$356K
- Kevin ZornChicago$274K
- Joshua MeeksChicago$248K
- Edward SchaefferChicago$209K
- Paul YonoverChicago$179K
- Omer RaheemChicago$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.